CRISPR Therapeutics
Gene-editing biotech developing transformative treatments for haematological disorders, oncology, and diabetes using CRISPR-Cas9 technology.
HighCompanies in this industry
Biotechnology and Digital Health
63 companies
View full industry profile →
Editas Medicine
Clinical-stage genome editing company developing CRISPR-based medicines targeting genetic diseases of the eye, blood, and liver.
HighBeam Therapeutics
Pioneer in precision base editing, developing treatments for sickle cell disease, blood cancers, and other serious genetic conditions.
HighPacific Biosciences
Developer of long-read single-molecule real-time DNA sequencing instruments enabling highly accurate genomic and epigenomic analysis.
HighTempus
AI-driven health technology company applying machine learning to genomic and clinical data to advance precision medicine and oncology care.
HighGinkgo Bioworks
Synthetic biology platform company engineering organisms for applications in pharmaceuticals, agriculture, food, and industrial chemicals.
HighModerna
Pioneering mRNA biotechnology company developing vaccines and therapeutics for infectious diseases, cancer, and rare genetic conditions.
HighBioNTech
German immunotherapy company globally known for its mRNA COVID-19 vaccine, with a broad oncology pipeline leveraging personalised cancer therapies.
HighIllumina
World's leading genomics company powering DNA sequencing technology used in research, clinical diagnostics, and precision medicine globally.
HighGlobal Mobility and Inclusion Index
The Global Mobility & Inclusion Index is AscendurePro's most original and most audience-specific framework.
Talent and Skills Demand Index
The Talent & Skills Demand Index is the bridge between AscendurePro's company intelligence layer and its career roadmap content.
Future-Readiness Index
The Future-Readiness Index evaluates how well-positioned a company is to remain competitive, relevant, and employer-worthy over the next 5–10 years.